221 related articles for article (PubMed ID: 7100216)
1. Plasmapheresis in myasthenia gravis.
Dau PC
Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis therapy in myasthenia gravis.
Dau PC
Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine.
Hohlfeld R; Toyka KV; Besinger UA; Gerhold B; Heininger K
Ann Neurol; 1985 Mar; 17(3):238-42. PubMed ID: 3873207
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of myasthenia gravis with plasmapheresis (author's transl)].
Reuther P; Wiebecke D; Hertel G; Böske A; Mertens HG
Dtsch Med Wochenschr; 1979 Dec; 104(51):1806-10. PubMed ID: 520174
[TBL] [Abstract][Full Text] [Related]
6. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of repeated plasma exchange in myasthenia gravis.
Newsom-Davis J; Wilson SG; Vincent A; Ward CD
Lancet; 1979 Mar; 1(8114):464-8. PubMed ID: 85055
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis in the treatment of myasthenia gravis.
Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
[TBL] [Abstract][Full Text] [Related]
11. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
Oosterhuis HJ; Limburg PC; Hummel-Tappel E; The TH
J Neurol Sci; 1983 Mar; 58(3):371-85. PubMed ID: 6842265
[TBL] [Abstract][Full Text] [Related]
12. Treatment of antenatal myasthenia gravis.
Carr SR; Gilchrist JM; Abuelo DN; Clark D
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):485-9. PubMed ID: 1870801
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
Nicholson GA; Griffiths LR
Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
Hawkey CJ; Newsom-Davis J; Vincent A
J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):469-75. PubMed ID: 7276959
[TBL] [Abstract][Full Text] [Related]
15. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
Patzold U; Kalies I; Haas J; Ginda EM
Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
[No Abstract] [Full Text] [Related]
16. Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis.
Bartges JW; Klausner JS; Bostwick EF; Hakala JE; Lennon VA
J Am Vet Med Assoc; 1990 Apr; 196(8):1276-8. PubMed ID: 2332375
[TBL] [Abstract][Full Text] [Related]
17. The effect of plasmapheresis on post-thymectomy ocular dysfunction.
Olanow CW; Roses AD; Fay JW
Can J Neurol Sci; 1981 May; 8(2):169-72. PubMed ID: 7296427
[TBL] [Abstract][Full Text] [Related]
18. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
Bau V; Hanisch F; Hain B; Zierz S
Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
